Although trust in pharma spiked during the pandemic, it seems companies' reputations are back to pre-COVID-19 levels—and there’s bad news for the biggest COVID vaccine makers. That’s according to a ...

World-class Kabuki theatre took the stage at the U.S. International Trade Commission (USITC) last week. Big Pharma interests raged en masse: Death and misery would befall us all if the U.S. government ...

Fosun Pharma’s revenue grew slightly in the first quarter on its diverse product portfolio, while its net profit soared by 116%. CanSino’s revenue plunged 80% in the same three-month period, and it ...

The financial performance of major pharmaceutical companies highlights the divergent trajectories of success of GLP-1 manufacturers and the weakness caused by diminishing Covid-19 sales. Eli Lilly and ...

Fosun Pharma’s net profit fell more than 20% last year due to a 30% drop in sales of its Comirnaty Covid vaccine and investment losses. The company’s innovative drugs generated more than 10 billion ...

By 2025, more than 13 billion doses of the vaccine are estimated to have been administered globally, saving untold millions of lives and suffering.

In the wake of the memo, several vaccine experts responded that the CBER director's claim about the deaths requires more ...

While Trump’s manufacturing and pricing deals with pharma shape the industry’s future, COVID’s impact still ripples ...

It’s about co-creating science.” The event highlighted pathogen research discoveries and pandemic prevention efforts from ...

The former pharmaceutical company CEO was convicted of securities fraud. A federal judge has rejected a request from Martin Shkreli, the infamous "Pharma Bro" fraudster, for a compassionate release ...